跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 俊佑
主治醫師
,
臺北市立萬芳醫院
成員
,
臺北醫學大學人工智慧醫療研究中心
https://orcid.org/0000-0002-8772-265X
電子郵件
99356
w.tmu.edu
tw
h-index
178
引文
8
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2017
2024
每年研究成果
概覽
指紋
網路
研究成果
(29)
資料集
(4)
類似的個人檔案
(6)
指紋
查看啟用 Chun-You Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Radiation Therapy
100%
Arteriovenous Fistula
90%
Maturation
50%
Hepatocellular Carcinoma
45%
Bone Metastasis
45%
Nuclear Magnetic Resonance
45%
Myofibroblast
45%
Progression Free Survival
37%
Overall Survival
35%
Prognostic Factor
28%
Observational Study
26%
Hemodialysis
25%
Neoplasm
24%
Liver Toxicity
22%
Glomerular Filtration Rate
22%
Tomotherapy
22%
Transcatheter Arterial Chemoembolization
22%
Emergency Care
22%
Neutrophil
22%
Lymphocyte
22%
Predictive Factor
22%
Stereotactic Body Radiation Therapy
22%
Ultrasound Surgery
22%
Systemic Therapy
22%
Prostate Cancer
22%
Attitude
22%
Intensity Modulated Radiation Therapy
22%
Left Lung
22%
Drug Dose Reduction
22%
Catenin
22%
Prostate Hypertrophy
22%
End Stage Renal Disease
22%
Atrial Fibrillation
22%
Oxidoreductase
22%
Urinary Retention
22%
Cyberknife
22%
Parathyroid Hormone
22%
Resuscitation
22%
Febuxostat
22%
Computerized Physician Order Entry
22%
Clinical Decision Support System
22%
Myopathy
22%
Disease
16%
Artery
16%
Patient Safety
15%
Odds Ratio
13%
Volunteer
11%
Student T Test
11%
Analysis of Variance
11%
Health Care
11%
Nursing and Health Professions
Pilot Study
67%
Dwell Time
45%
Ward
45%
University Hospital
39%
Likert Scale
33%
Computerized Physician Order Entry
28%
Mobile Application
22%
Bibliometric Review
22%
Filter
22%
Neutrophil Lymphocyte Ratio
22%
Liver Cell Carcinoma
22%
Control System
22%
Ultrasound Surgery
22%
Radiotherapy
22%
Bone Metastasis
22%
Emergency Care
22%
Liver Toxicity
22%
Resuscitation
22%
Clinical Decision Support System
22%
Content Analysis
22%
Nursing Staff
22%
Content Validity
22%
Arteriovenous Fistula
22%
Nuclear Magnetic Resonance
22%
Oncology Nursing
22%
Receiver Operating Characteristic
15%
Confidence Interval
13%
Odds Ratio
11%
Multivariate Logistic Regression Analysis
11%
Karnofsky Performance Status
11%
Student T Test
11%
Self-Efficacy
11%
Health Service
11%
Volunteer
11%
Medical Personnel
11%
Medical Law
11%
Analysis of Variance
11%
Automated External Defibrillator
11%
Patient Care
11%
Overall Survival
10%
Patient Safety
10%
Bibliometrics
9%
Outpatient Department
5%
Numeric Rating Scale
5%
Tumor Volume
5%
Cancer Center
5%
Clinical Feature
5%
Imaging
5%
Local Therapy
5%
Computer Assisted Tomography
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
47%
Progression Free Survival
45%
Hemodialysis
45%
Arteriovenous Fistula
45%
Overall Survival
33%
Adverse Event
28%
Neoplasm
28%
End Stage Renal Disease
24%
Heart Failure
23%
Liver Cell Carcinoma
22%
Myopathy
22%
Valsartan/Sacubitril
22%
Febuxostat
22%
Prostate Hypertrophy
22%
Clinical Feature
22%
Oxidoreductase
22%
Urine Retention
22%
Staphylococcal Infection
22%
Retrospective Study
22%
Parathyroid Hormone
22%
Atrial Fibrillation
22%
Cohort Study
19%
Dipyridamole
15%
Lung Tumor
11%
Malignant Neoplasm
11%
Liver Disease
11%
Liver Cancer
11%
Infectious Agent
11%
Staphylococcus Aureus
11%
Cancer Staging
11%
Survival Rate
9%
Antithrombocytic Agent
9%
ICD-9
7%
Valsartan
6%
Observational Study
5%
Recurrent Disease
5%
Solid Malignant Neoplasm
5%
Dutasteride
5%
Prostate Specific Antigen
5%